Loading...
XSHG
600511
Market cap3.12bUSD
Dec 05, Last price  
29.23CNY
1D
-0.31%
1Q
-0.98%
Jan 2017
-2.89%
IPO
1,013.98%
Name

China National Medicines Corporation Ltd

Chart & Performance

D1W1MN
XSHG:600511 chart
P/E
11.03
P/S
0.44
EPS
2.65
Div Yield, %
2.92%
Shrs. gr., 5y
-0.20%
Rev. gr., 5y
2.54%
Revenues
50.60b
+1.81%
2,333,882,1072,807,039,7153,573,788,0104,385,472,4695,194,599,5355,918,037,6147,042,245,9418,591,632,46210,081,474,20611,538,342,52112,078,194,12413,386,417,45336,284,746,32838,739,827,10444,644,476,40440,378,608,10746,468,602,84445,498,583,76449,696,045,52850,597,449,788
Net income
2.00b
-6.80%
50,370,39684,611,244131,102,366193,825,940226,599,176310,019,181271,261,168335,815,809411,509,713482,653,724512,845,021547,606,9051,141,484,9491,404,095,4001,603,898,6861,382,688,4361,754,084,2181,964,057,5592,145,998,7462,000,126,943
CFO
1.66b
-39.15%
92,199,043121,497,89979,475,727217,095,150255,178,001318,212,8510185,868,315185,563,414218,943,203440,285,456591,250,4271,074,491,395981,654,0681,776,070,4911,301,671,1041,957,451,0322,395,123,4542,726,657,0971,659,119,523
Dividend
Jun 13, 20240.854 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.
IPO date
Nov 27, 2002
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT